Alloferon is our company’s representative new drug candidate development and it is currently available in the market as an antivirus. Alloferon is a linear peptide with a molecular weight of 1,265 Dalton, which has been derived from the immune substance of infected fruit flies. According to a variety of research activities, it has been proven to increase the Natural Killer Cell activities, induces various selective Cytokine synthesis in the human body, and it is also proven to have a wide-range of antivirus, anti-cancer, anti-inflammatory, and anti-allergenic effects through immune modulating activities.
Alloferon is absorbed quickly into the body and remains in the body for an extended period of time to maximize its efficacy. Especially, it is available in the market as a Class 1 new drug substance in the non-toxic medicine category.